Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Glaukos Corp    GKOS

GLAUKOS CORP (GKOS)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/19/2018 09/20/2018 09/21/2018 09/24/2018 09/25/2018 Date
59.94(c) 60.45(c) 58.84(c) 60.72(c) 63.1 Last
494 613 313 526 712 069 318 902 525 908 Volume
-3.85% +0.85% -2.66% +3.20% +3.92% Change
More quotes
Financials (USD)
Sales 2018 177 M
EBIT 2018 -15,0 M
Net income 2018 -14,0 M
Finance 2018 93,5 M
Yield 2018 -
Sales 2019 227 M
EBIT 2019 0,28 M
Net income 2019 2,15 M
Finance 2019 132 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019 9 062,69
EV / Sales2018 11,6x
EV / Sales2019 8,83x
Capitalization 2 141 M
More Financials
Company
Glaukos Corp. is an ophthalmic medical device company, which engages in the development and commercialization of surgical devices and sustained pharmaceutical therapies designed to treat glaucoma.Its Micro Invasive Glaucoma Surgery procedures are designed to reduce intraocular eye pressure by... 
Sector
Medical Equipment, Supplies & Distribution
Calendar
09/24 | 08:00amPresentation
More about the company
Surperformance© ratings of Glaukos Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on GLAUKOS CORP
09/21GLAUKOS : Multiple Surgeon Presentations to Showcase Glaukos Products at 2018 Eu..
BU
09/05GLAUKOS CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form..
AQ
08/30TODAY'S RESEARCH REPORTS ON TRENDING : Glaukos and STAAR Surgical
AC
08/29WEDNESDAY SECTOR LEADERS : Drugs, Medical Instruments & Supplies
AQ
08/29GLAUKOS : Rises After Competitor Recalls Glaucoma Device -- Market Mover
DJ
08/22GLAUKOS : Announces Participation in Wells Fargo Healthcare Conference
BU
08/09GLAUKOS : Announces Pharmaceutical Development Agreement with D. Western Therape..
AQ
08/06GLAUKOS : Management's Discussion and Analysis of Financial Condition and Result..
AQ
08/04GLAUKOS : Announces Pharmaceutical Development Agreement With D. Western Therape..
AQ
08/03GLAUKOS : 2Q Earnings Snapshot
AQ
More news
Sector news : Medical Devices & Implants
04:14pHENRY SCHEIN : to Acquire Ownership in Three Dental Implant Companies
DJ
09/21Disruption to medical business takes toll on Smiths Group
RE
09/21MAZOR ROBOTICS : Medtronic to acquire Mazor in $1.64 billion deal
RE
09/21MEDTRONIC : to Acquire Mazor Robotics for $1.64 Billion
DJ
09/13Smiths and ICU Medical healthcare merger talks collapse
RE
More sector news : Medical Devices & Implants
Latest Tweets
05:07p$GKOS Daily. Little medical device play trying to move up and out of tight ch..
1
09/21NEW POST: New Post/Video: Buyout Plays and Beyond 09/21/18 {Video}
1
09/17Glaukos Corp $GKOS Expected to Post Quarterly Sales of $41.52 Million  
09/17Analysts Anticipate Glaukos Corp $GKOS Will Announce Earnings of -$0.12 Per S.. 
09/13Glaukos $GKOS Given New $70.00 Price Target at Stephens  
More tweets
Qtime:219
News from SeekingAlpha
08/30Premarket analyst action - healthcare 
08/29JPMorgan bullish on Glaukos after Alcon stent exit; sees 24% upside 
08/29Midday Gainers / Losers (08/29/2018) 
08/29HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am (08/29/2018) 
08/29PREMARKET GAINERS AS OF 9 : 05 am (08/29/2018) 
Chart GLAUKOS CORP
Duration : Period :
Glaukos Corp Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLAUKOS CORP
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 68,4 $
Spread / Average Target 13%
EPS Revisions
Managers
NameTitle
Thomas William Burns President, Chief Executive Officer & Director
William J. Link Chairman
Chris M. Calcaterra Chief Operating Officer
Joseph E. Gilliam CFO & Senior VP-Corporate Development
Harold A. Heitzmann Senior VP-Applied Research & Engineering
Sector and Competitors
1st jan.Capitalization (M$)
GLAUKOS CORP129.40%2 141
STRYKER CORPORATION13.72%65 852
SMITH & NEPHEW7.41%15 818
WRIGHT MEDICAL GROUP NV26.13%3 498
DOUBLE MEDICAL TECHNOLOGY INC--.--%1 690
JAPAN LIFELINE CO., LTD.-11.67%1 673